Motor evoked potential polyphasia: a novel endophenotype of idiopathic generalized epilepsy.
OBJECTIVE
We compared the motor evoked potential (MEP) phases using transcranial magnetic stimulation in patients with idiopathic generalized epilepsy (IGE), their relatives, and healthy controls, hypothesizing that patients and their unaffected relatives may share a subtle pathophysiologic abnormality.


METHODS
In a cross-sectional study, we investigated 23 patients with IGE, 34 first-degree relatives, and 30 matched healthy controls. Transcranial magnetic stimulation was performed to produce a series of suprathreshold single-pulse MEPs. A semiautomated method was used to count phases. We compared between groups the mean number of MEP phases, the stimulus-to-stimulus variability in MEP phases, and the proportion of polyphasic MEPs within subjects.


RESULTS
Patients with IGE and their relatives had a significantly increased number of MEP phases (median for patients 2.24, relatives 2.17, controls 2.01) and a significantly higher proportion of MEPs with more than 2 phases than controls (median for patients 0.118, relatives 0.088, controls 0.013). Patients had a greater stimulus-to-stimulus variability in number of MEP phases than controls. There were no differences between patients and relatives.


CONCLUSIONS
Increased MEP polyphasia in patients with IGE and their first-degree relatives may reflect transient abnormal evoked oscillations. The presence of polyphasic MEPs in relatives as well as patients suggests that MEP polyphasia is not related to treatment, and is in isolation insufficient to predispose to epilepsy. Polyphasic MEP may be a novel endophenotype in IGE.
From the Department of Clinical Neuroscience (F.A.C., A.D.P., B.C., M.P.R.) and Centre for Epilepsy (L.N., R.D.C.E.), King's College London, UK.
Fahmida A
FA
Chowdhury
From the Department of Clinical Neuroscience (F.A.C., A.D.P., B.C., M.P.R.) and Centre for Epilepsy (L.N., R.D.C.E.), King's College London, UK. adam.pawley@kcl.ac.uk.
Adam D
AD
Pawley
From the Department of Clinical Neuroscience (F.A.C., A.D.P., B.C., M.P.R.) and Centre for Epilepsy (L.N., R.D.C.E.), King's College London, UK.
Bryan
B
Ceronie
From the Department of Clinical Neuroscience (F.A.C., A.D.P., B.C., M.P.R.) and Centre for Epilepsy (L.N., R.D.C.E.), King's College London, UK.
Lina
L
Nashef
From the Department of Clinical Neuroscience (F.A.C., A.D.P., B.C., M.P.R.) and Centre for Epilepsy (L.N., R.D.C.E.), King's College London, UK.
Robert D C
RD
Elwes
From the Department of Clinical Neuroscience (F.A.C., A.D.P., B.C., M.P.R.) and Centre for Epilepsy (L.N., R.D.C.E.), King's College London, UK.
Mark P
MP
Richardson
D000293:Adolescent; D000328:Adult; D016022:Case-Control Studies; D003430:Cross-Sectional Studies; D058068:Endophenotypes; D004829:Epilepsy, Generalized / Q000503:physiopathology*; D019054:Evoked Potentials, Motor / Q000502:physiology*; D005190:Family; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D050781:Transcranial Magnetic Stimulation; D055815:Young Adult